Table 1 Biopharma companies and their internal AI programs : This table highlights key companies, AI partners, and their associated programs, emphasizing real-world applications in drug discovery, clinical trial management, personalized medicine, and more. It includes major platforms such as BenevolentAI, Insilico Medicine, DeepMind, and tools like AlphaFold that are shaping the biotechnology landscape
Biopharmaceutical Firm | AI Partner/Technology | AI Program Name | Focus Area | Key Details |
|---|---|---|---|---|
Pfizer | IBM Watson and GNS Healthcare | Pfizer AI | Drug discovery and development | Uses AI to optimize molecular design and streamline clinical trials |
Roche | PathAI and Tempus | AI Pathway Explorer | Personalized medicine | Focused on patient stratification and biomarker discovery |
Novartis | Microsoft AI for Healthcare; internal AI platforms | Nerve | Clinical trial management | AI-driven clinical trial recruitment and predictive modeling |
Johnson & Johnson | BenevolentAI and XtalPi | Janssen AI | Drug development | AI for molecule screening and toxicity prediction |
AstraZeneca | BenevolentAI and DeepMind | AI BioPharma | Genomics and drug discovery | Leveraging AI for genomic data analysis to develop novel therapies |
GlaxoSmithKline (GSK) | Exscientia and Insilico Medicine | GSK.AI | Vaccine and therapeutic design | Focused on AI-driven vaccine optimization and novel therapeutic candidates |
Sanofi | Recursion Pharmaceuticals and BioSymetrics | AI Health | Drug repurposing | Uses AI to identify new applications for existing drugs |
Merck | Atomwise and Google Cloud AI | Merck AI Labs | Clinical trial insights | AI for improving trial design and real-time patient monitoring |
Bayer | Blackford Analysis and Sensyne Health | LEAP AI | Drug discovery and crop sciences | Integrates AI in healthcare and agricultural solutions |
AbbVie | AI startups like Iktos and Cytel | AbbVie AI | Antibody development | Focused on AI to design next-generation antibody-based therapies |
